Jan 20, 2022
SAN FRANCISCO --(BUSINESS WIRE)--Jan. 20, 2022-- Better Therapeutics, Inc. (“Better Therapeutics”; NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing cognitive behavioral therapy to address root causes of cardiometabolic diseases, today announced that Kevin Appelbaum ,
Oct 29, 2021
Trading to commence on Nasdaq on Oct. 29, 2021 , under the ticker symbol BTTX SAN FRANCISCO & NEW YORK --(BUSINESS WIRE)--Oct. 29, 2021-- Better Therapeutics, Inc. , a prescription digital therapeutics (PDT) company delivering cognitive behavioral therapy to address the root causes of
Displaying 11 - 20 of 41